Health Care Coverage Determinations: An International Comparative Study
Based upon research from Australia, Canada, Germany, The Netherlands, Spain, Switzerland, the United States of America and the United Kingdom, the contributors of this book argue that although each of these countries is committed to evidence-based scientific assessment of technologies, in fact adoption of technologies is significantly affected by political considerations, and in particular by the influence of interest groups. Moreover, it offers recommendations as to how technology assessment for coverage policy can be improved to serve better the public interest.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Chapter 01 METHODOLOGICAL INTRODUCTION
THE AUSTRALIAN EXPERIENCE
TECHNOLOGY ASSESSMENT IN CANADIAN MEDICARE
Chapter 04 EVALUATING NEW HEALTH TECHNOLOGY IN THE ENGLISH NATIONAL HEALTH SERVICE
Chapter 05 BENEFIT DECISIONS IN GERMAN SOCIAL HEALTH INSURANCE
Chapter 06 HEALTH CARE COVERAGE IN THE NETHERLANDS THE DUTCH DRUG REIMBURSEMENT SCHEME GVS
Chapter 07 HEALTH CARE COVERAGE DETERMINATIONS IN SPAIN
accessed 24 Feb agency amantadine ambulatory appeal application appraisal approval Australia budget CAHTA Canada cancer CCOHTA cent chronic myeloid leukaemia Commission considered cost effectiveness countries coverage decisions coverage determinations coverage policy covered criteria decision-making Department of Health diagnostic drug economic efficacy evaluation evidence expert Federal Committee Glivec guidance guidelines HBOT health care system health insurance health services Health Technology Assessment hospital hyperbaric oxygen therapy imatinib indications institutions limited MCAC Medicare medicine MinVWS MSAC national coverage national coverage determination Netherlands NICE Ontario oseltamivir Panel patient groups PBAC PCTs PET scanning Pharmaceutical Benefits pharmacoeconomic physician Positron Emission Tomography procedures providers provincial public funding public health public insurance recommendation reimbursement request response sector sickness funds Sickness Insurance social health insurance social insurance sponsors studies Switzerland therapeutic therapy thyroid cancer treatment zanamivir